Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults.
Symons HJ, Zahurak M, Cao Y, Chen A, Cooke K, Gamper C, Klein O, Llosa N, Zambidis ET, Ambinder R, Bolaños-Meade J, Borrello I, Brodsky R, DeZern A, Gojo I, Showel M, Swinnen L, Smith BD, Luznik L, Jones RJ, Fuchs EJ.
Symons HJ, et al.
Blood Adv. 2020 Aug 25;4(16):3913-3925. doi: 10.1182/bloodadvances.2020001648.
Blood Adv. 2020.
PMID: 32813874
Free PMC article.
Clinical Trial.